We are live on
!
Find out more
SGAM
Smith Group Asset Management Portfolio holdings
AUM
$2.46B
Turnover
25.53%
1-Year Est. Return
57.16%
This Fund
S&P 500
This Quarter
Est. Return
+5.13%
1 Year Est. Return
+57.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.31B
AUM Growth
–
Cap. Flow
+$2.29B
Cap. Flow
% of AUM
99.1%
Top 10 Holdings %
Top 10 Hldgs %
20.5%
Holding
404
New
404
Increased
–
Reduced
–
Closed
–
Avg Time Held
0
years
Top 10 Avg Time Held
0
years
Top 20 Avg Time Held
0
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Home Depot
HD
|
+$54.2M |
| 2 |
Booking.com
BKNG
|
+$51.5M |
| 3 |
Kroger
KR
|
+$50.8M |
| 4 |
ResMed
RMD
|
+$50M |
| 5 |
NetApp
NTAP
|
+$48.2M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.37% |
| 2 | Consumer Discretionary | 17.12% |
| 3 | Healthcare | 15.8% |
| 4 | Financials | 12.61% |
| 5 | Industrials | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $1.23M | 0.05% |
+1,134
| New | +$1.26M |
2013 Q2
0 quarters
|
|
|
OREX
177
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $1.21M | 0.05% |
+20,750
| New | +$1.28M |
2013 Q2
0 quarters
|
|
178
Lexicon Pharmaceuticals
LXRX
$699M
| $1.16M | 0.05% |
+76,494
| New | +$1.16M |
2013 Q2
0 quarters
|
|
179
DELISTED
American Woodmark
AMWD
| $1.08M | 0.05% |
+31,271
| New | +$1.07M |
2013 Q2
0 quarters
|
|
180
Rollins
ROL
$16.1B
| $1.03M | 0.04% |
+133,650
| New | +$960K |
2013 Q2
0 quarters
|
|
181
ICU Medical
ICUI
$4.12B
| $999K | 0.04% |
+13,855
| New | +$916K |
2013 Q2
0 quarters
|
|
182
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $976K | 0.04% |
+18,411
| New | +$807K |
2013 Q2
0 quarters
|
|
183
Magnera Corp
MAGN
$401M
| $966K | 0.04% |
+2,961
| New | +$940K |
2013 Q2
0 quarters
|
|
184
Delek US
DK
$4.66B
| $916K | 0.04% |
+31,840
| New | +$1.12M |
2013 Q2
0 quarters
|
|
|
PGNX
185
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $905K | 0.04% |
+202,820
| New | +$910K |
2013 Q2
0 quarters
|
|
|
KYTH
186
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $899K | 0.04% |
+33,220
| New | +$760K |
2013 Q2
0 quarters
|
|
|
ANN
187
DELISTED
ANN INC
ANN
| $882K | 0.04% |
+26,573
| New | +$806K |
2013 Q2
0 quarters
|
|
188
Coca-Cola Consolidated
COKE
$13.9B
| $869K | 0.04% |
+142,180
| New | +$867K |
2013 Q2
0 quarters
|
|
|
GEVA
189
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $862K | 0.04% |
+20,531
| New | +$936K |
2013 Q2
0 quarters
|
|
190
Incyte
INCY
$22.8B
| $799K | 0.03% |
+36,315
| New | +$793K |
2013 Q2
0 quarters
|
|
|
NRCIB
191
DELISTED
National Research Corp Class B
NRCIB
| $783K | 0.03% |
+22,406
| New | +$789K |
2013 Q2
0 quarters
|
|
192
Evercore
EVR
$9.84B
| $763K | 0.03% |
+19,406
| New | +$752K |
2013 Q2
0 quarters
|
|
193
Ceco Environmental
CECO
$3.47B
| $719K | 0.03% |
+58,473
| New | +$705K |
2013 Q2
0 quarters
|
|
194
Artivion
AORT
$1.06B
| $704K | 0.03% |
+112,400
| New | +$686K |
2013 Q2
0 quarters
|
|
195
Domino's
DPZ
$10.1B
| $693K | 0.03% |
+11,910
| New | +$666K |
2013 Q2
0 quarters
|
|
196
Achieve Life Sciences
ACHV
$650M
| $648K | 0.03% |
+30
| New | +$671K |
2013 Q2
0 quarters
|
|
|
NAVG
197
DELISTED
Navigators Group Inc
NAVG
| $643K | 0.03% |
+22,538
| New | +$657K |
2013 Q2
0 quarters
|
|
|
TOWR
198
DELISTED
Tower International, Inc.
TOWR
| $642K | 0.03% |
+32,430
| New | +$567K |
2013 Q2
0 quarters
|
|
199
Bank OZK
OZK
$5.01B
| $638K | 0.03% |
+29,458
| New | +$627K |
2013 Q2
0 quarters
|
|
|
PDLI
200
DELISTED
PDL BioPharma, Inc.
PDLI
| $628K | 0.03% |
+81,327
| New | +$634K |
2013 Q2
0 quarters
|
|
Similar funds
MAMU
PC
RG
DIA
Smith Group Asset Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Smith Group Asset Management, which disclosed 404 positions worth $2.31B. Its ten largest holdings account for 21% of the portfolio.
Its largest position is Home Depot: 720,749 shares worth $55.9M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, followed by Consumer Discretionary and Healthcare.
- Smith Group Asset Management's largest Q2 2013 buy was Home Depot: 720,749 shares worth $55.9M.
- Smith Group Asset Management's ten largest holdings make up 21% of its $2.31B portfolio in Q2 2013.
- Smith Group Asset Management disclosed 404 positions in Q2 2013, its first 13F filing on record.
Based on Smith Group Asset Management's 13F filing for Q2 2013, filed 30 Jul 2013.